World News in Dutch
Июль
2016

Новости за 21.07.2016

United Press International (UPI.com) 

Cord blood cells used to treat macular degeneration in trial

Stephen Feller
CHICAGO, July 21 (UPI) -- Multipotent cells from umbilical cord blood are being tested as a treatment for the most common form of macular degeneration, potentially restoring vision.

TheRepublic.com 

Doc still wearing bloody shoes 6 weeks after Pulse shooting

ORLANDO, Fla. — A senior resident at an Orlando hospital is still wearing the bloody shoes he wore as he treated victims from the Pulse nightclub shooting. Shortly after the June 12 shooting, Dr. Joshua Corsa wrote a moving Facebook status and posted a photo of his sneakers that were bloodied as 44 patients from

«Gazette Times» (gazettetimes.com) 

'Star Trek Beyond' premieres at Comic-Con

SAN DIEGO (AP) — The world premiere of "Star Trek Beyond" blasted off at Comic-Con with an orchestra, fireworks, lasers and tributes to the series' late stars.

JournalStar.com 

'Star Trek Beyond' premieres at Comic-Con

SAN DIEGO (AP) — The world premiere of "Star Trek Beyond" blasted off at Comic-Con with an orchestra, fireworks, lasers and tributes to the series' late stars.

«Gazette Times» (gazettetimes.com) 

Greece: 8 Turkish military personnel sentenced to 2 months

ALEXANDROUPOLIS, Greece (AP) — A Greek court on Thursday sentenced eight Turkish military personnel who fled to Greece aboard a helicopter during an attempted coup in their country to two months in prison on charges of illegal entry into Greece.

WSJ.com 

U.S. Jobless Claims Edged Lower Last Week

The number of Americans filing new applications for jobless benefits fell last week, a sign the labor market could continue its expansion into the second half of the year.

TheRepublic.com 

Biogen beats Street 2Q forecasts

CAMBRIDGE, Mass. — CAMBRIDGE, Mass. — Biogen Inc. (BIIB) on Thursday reported second-quarter net income of $1.05 billion. On a per-share basis, the Cambridge, Massachusetts-based company said it had net income of $4.79. Earnings, adjusted for one-time gains and costs, were $5.21 per share. The results topped Wall Street expectations. The average estimate of 20